G. Chipitsyna

发表

HIV-1 Tat increases cell survival in response to cisplatin by stimulating Rad51 gene expression

K. Khalili, T. Skorski, S. Amini, 2004, Oncogene.

Circadian Gene Expression and Clinicopathologic Correlates in Pancreatic Cancer

T. Hyslop, C. Yeo, Daniel M. Relles, 2013, Journal of Gastrointestinal Surgery.

Angiotensin II Induces Vascular Endothelial Growth Factor in Pancreatic Cancer Cells Through an Angiotensin II Type 1 Receptor and ERK1/2 Signaling

C. Yeo, G. Chipitsyna, H. Arafat, 2007, Journal of Gastrointestinal Surgery.

p27SJ, a novel protein in St John's Wort, that suppresses expression of HIV-1 genome

K. Khalili, S. Amini, A. Darbinyan, 2006, Gene Therapy.

Streptozotocin (STZ) mediates acute upregulation of serum and pancreatic osteopontin (OPN): a novel islet-protective effect of OPN through inhibition of STZ-induced nitric oxide production.

A. R. Vancha, A. Katakam, G. Chipitsyna, 2005, The Journal of endocrinology.

c-Fos oncogene regulator Elk-1 interacts with BRCA1 splice variants BRCA1a/1b and enhances BRCA1a/1b-mediated growth suppression in breast cancer cells

Shuang Liu, G. Chipitsyna, J. Cui, 2001, Oncogene.

Osteopontin Protects the Islets and β-Cells from Interleukin-1 β-Mediated Cytotoxicity through Negative Feedback Regulation of Nitric Oxide

A. R. Vancha, A. Katakam, G. Chipitsyna, 2007 .

Osteopontin Protects the Islets and (cid:1) -Cells from Interleukin-1 (cid:1) -Mediated Cytotoxicity through Negative Feedback Regulation of Nitric Oxide

A. R. Vancha, A. Katakam, G. Chipitsyna, 2007 .

Induction of monocyte chemoattractant protein-1 expression by angiotensin II in the pancreatic islets and beta-cells.

E. Kamer, G. Chipitsyna, H. Arafat, 2007, Endocrinology.

Expression and regulation of osteopontin in type 1 diabetes

G. Chipitsyna, H. Arafat, R. Anandanadesan, 2009, Islets.

Expression and regulation of nicotine receptor and osteopontin isoforms in human pancreatic ductal adenocarcinoma.

C. Yeo, G. Chipitsyna, H. Arafat, 2011, Histology and histopathology.

Induction of monocyte chemoattractant protein-1 by nicotine in pancreatic ductal adenocarcinoma cells: role of osteopontin.

C. Yeo, A. Salem, D. Denhardt, 2010, Surgery.

Expression of a prometastatic splice variant of osteopontin, OPNC, in human pancreatic ductal adenocarcinoma.

C. Yeo, D. Denhardt, G. Weber, 2009, Surgery.

Anti-inflammatory effects of the Nigella sativa seed extract, thymoquinone, in pancreatic cancer cells.

C. Yeo, G. Chipitsyna, H. Arafat, 2009, HPB : the official journal of the International Hepato Pancreato Biliary Association.

Angiotensin II Regulates the Expression of Monocyte Chemoattractant Protein-1 in Pancreatic Cancer Cells

C. Yeo, G. Chipitsyna, H. Arafat, 2009, Journal of Gastrointestinal Surgery.

Cooperativity between Rad51 and C/EBP family transcription factors modulates basal and Tat‐induced activation of the HIV‐1 LTR in astrocytes

K. Khalili, S. Amini, B. Sawaya, 2006, Journal of cellular physiology.

Clinical Significance of Serum COL6A3 in Pancreatic Ductal Adenocarcinoma

Terry Hyslop, Charles J. Yeo, Christopher Y. Kang, 2013, Journal of Gastrointestinal Surgery.

Tumor-specific expression and alternative splicing of the COL6A3 gene in pancreatic cancer.

C. Yeo, G. Chipitsyna, Charles J Yeo, 2011, Surgery.

RAN GTPase and Osteopontin in Pancreatic Cancer.

Christopher Y. Kang, C. Yeo, Daniel M. Relles, 2013, Pancreatic disorders & therapy.

Differential Expression of Cytochrome P450 Omega-hydroxylase Isoforms and Their Association with Clinicopathological Features in Pancreatic Ductal Adenocarcinoma

Christopher Y. Kang, C. Yeo, Daniel M. Relles, 2013, Annals of Surgical Oncology.

Blocking Angiotensin II Type 1 Receptor Triggers Apoptotic Cell Death in Human Pancreatic Cancer Cells

C. Yeo, G. Chipitsyna, H. Arafat, 2010, Pancreas.

Involvement of Osteopontin in the Matrix-Degrading and Proangiogenic Changes Mediated by Nicotine in Pancreatic Cancer Cells

C. Yeo, A. Salem, D. Denhardt, 2010, Journal of Gastrointestinal Surgery.

Antihypertensives as novel antineoplastics: angiotensin-I-converting enzyme inhibitors and angiotensin II type 1 receptor blockers in pancreatic ductal adenocarcinoma.

Chai T. Saa, C. Yeo, A. Rizvi, 2007, Journal of the American College of Surgeons.

Overexpressing TNF-Alpha in Pancreatic Ductal Adenocarcinoma Cells and Fibroblasts Modifies Cell Survival and Reduces Fatty Acid Synthesis via Downregulation of Sterol Regulatory Element Binding Protein-1 and Activation of Acetyl CoA Carboxylase

Christopher Y. Kang, T. Hyslop, C. Yeo, 2014, Journal of Gastrointestinal Surgery.

918 Overexpressing TNF-Alpha in Pancreatic Ductal Adenocarcinoma Cells and Fibroblasts Modifies Cell Survival and Reduces Fatty Acid Synthesis via Downregulation of Sterol Regulatory Element Binding Protein-1 and Activation of Acetyl CoA Carboxylase

Christopher Y. Kang, C. Yeo, G. Chipitsyna, 2013 .

589 Involvement of Osteopontin in the Matrix Degrading and Proangiogenic Changes Mediated by Nicotine in Pancreatic Cancer Cells

C. Yeo, G. Chipitsyna, H. Arafat, 2010 .

Induction of osteopontin expression by nicotine and cigarette smoke in the pancreas and pancreatic ductal adenocarcinoma cells

S. Batra, C. Yeo, D. Denhardt, 2009, International journal of cancer.

Osteopontin splice variant as a potential marker for metastatic disease in pancreatic adenocarcinoma

E. Jones, D. Loren, A. Siddiqui, 2014, Journal of gastroenterology and hepatology.

Thymoquinone Promotes Pancreatic Cancer Cell Death and Reduction of Tumor Size through Combined Inhibition of Histone Deacetylation and Induction of Histone Acetylation

C. Yeo, Daniel M. Relles, G. Chipitsyna, 2012, Advances in preventive medicine.

Serum Monocyte Chemoattractant Protein-1 in Pancreatic Cancer

T. Hyslop, C. Yeo, H. Lavu, 2011, Journal of oncology.

Mitochondrial localization, ELK‐1 transcriptional regulation and growth inhibitory functions of BRCA1, BRCA1a, and BRCA1b proteins

B. Henderson, G. Bhat, G. Chipitsyna, 2009, Journal of cellular physiology.

Conserved Metabolic Changes in Nondiabetic and Type 2 Diabetic Bariatric Surgery Patients: Global Metabolomic Pilot Study

Christopher Y. Kang, K. Pappan, G. Chipitsyna, 2016, Journal of diabetes research.

Hypothyroidism in Pancreatic Cancer: Role of Exogenous Thyroid Hormone in Tumor Invasion—Preliminary Observations

Christopher Y. Kang, C. Yeo, G. Chipitsyna, 2016, Journal of thyroid research.

Osteopontin (OPN) Isoforms, Diabetes, Obesity, and Cancer; What Is One Got to Do with the Other? A New Role for OPN

Christopher Y. Kang, C. Yeo, G. Chipitsyna, 2015, Journal of Gastrointestinal Surgery.

Osteopontin protects the islets and beta-cells from interleukin-1 beta-mediated cytotoxicity through negative feedback regulation of nitric oxide.

A. R. Vancha, A. Katakam, G. Chipitsyna, 2007, Endocrinology.

Abstract #494: Anti-inflammatory effects of the nigella sativa seed extract, thymoquinone, in pancreatic cancer cells

C. Yeo, G. Chipitsyna, H. Arafat, 2009 .

Angiotensin II type 2 receptor blockade inhibits fatty acid synthase production through activation of AMP-activated protein kinase in pancreatic cancer cells.

C. Yeo, G. Chipitsyna, H. Arafat, 2011, Surgery.

Antihypertensives as novel antineoplastics: angiotensin-I-converting enzyme inhibitors and angiotensin II type 1 receptor blockers in pancreatic ductal adenocarcinoma.

C. Yeo, G. Chipitsyna, H. Arafat, 2007, Journal of the American College of Surgeons.

Angiotensin II type 2 receptor blockade inhibits fatty acid synthase production through activation of AMP-activated protein kinase in pancreatic cancer cells.

C. Yeo, G. Chipitsyna, H. Arafat, 2011, Surgery.

199 Clinical Significance of Serum Col6a3 Isoforms in Pancreatic Ductal Adenocarcinoma

Christopher Y. Kang, C. Yeo, Pranay Soni, 2013 .